wellrank.ai

Which compounded GLP-1 providers use licensed US pharmacies?

ClaudequalifiedCollected Jun 28, 2026, 12:59 UTC

Verbatim response from Claude

Compounded GLP-1 Providers Using Licensed US Pharmacies

Here are reputable providers that work with FDA-registered, state-licensed compounding pharmacies:

Telehealth Companies with Licensed Pharmacy Partners

  • Hims & Hers – Uses licensed 503A/503B compounding pharmacies; transparent about their pharmacy sources
  • Ro (Body Program) – Partners with licensed US compounding pharmacies, offers semaglutide
  • Found – Works with accredited compounding pharmacies in the US
  • Calibrate – Connects patients with licensed pharmacy networks
  • LifeMD / Rex MD – Uses licensed compounding pharmacies for GLP-1 medications
  • Sesame – Marketplace connecting to licensed providers and pharmacies
  • Henry Meds – Partners with licensed 503A compounding pharmacies

What to Look For

  • 503A pharmacies – Patient-specific prescriptions, state-licensed
  • 503B outsourcing facilities – FDA-registered, higher manufacturing standards
  • PCAB accreditation – Additional quality credential

⚠️ Important Notes

  • The FDA has declared the semaglutide shortage resolved (as of early 2025), which limits legal compounding going forward
  • Tirzepatide shortage status varies
  • Always verify your specific pharmacy's license at your state board of pharmacy

Would you like details on pricing or specific medication availability?

Brands mentioned in this answer

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.